← Back to headlines
Legend Bio Stock Rises on Positive Early-Stage CAR-T Therapy Data
Legend Biotech's stock saw an increase following the release of promising early-stage data for its in vivo CAR-T therapy.
2 Jun, 15:07 — 2 Jun, 15:07
Sources
Showing 1 of 1 sources
